CLOs on the Move

Knight Therapeutics Inc

www.gud-knight.com

 
Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets. Knight Therapeutics' shares are expected to begin trading on the TSX-V on March 3, 2014 under the symbol GUD.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.gud-knight.com
  • 376 Victoria Ave Suite 220
    Westmount, ON CAN H3Z 1C3
  • Phone: 514.481.4116

Executives

Name Title Contact Details

Similar Companies

Business Process Management for Healthcare

BPM+ Health™ is a community initiative to improve the quality and consistency of healthcare delivery. It will achieve this by applying business process modeling standards to clinical best practices, care pathways and workflows directly at the point of care. It is a cross-discipline group of professional organizations, clinical societies, and healthcare providers working together to develop and pilot standards-driven healthcare process automation techniques to fully realize the benefits of Healthcare IT. Founding Members: American College of Emergency Physicians (ACEP), Auxilium Technology Group, EvidenceCare, Mayo Clinic, MDIX, Perspecta, Red Hat, Trisotech, University of Utah, University of Washington, U.S. Department of Veterans Affairs Industry Supporters: HIMSS, HL7, HSPC, NCQA, AHRQ BPM+ Health is a program of the Object Management Group® (OMG®).

Doheny Eye Institute

Doheny Eye Institute is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Doheny Eye Institute is based in Los Angeles, CA. You can find more information on Doheny Eye Institute at www.doheny.org

Nexus

Nexus is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Louisiana State Nurses Association

Louisiana State Nurses Association is a Baton Rouge, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SynGen

SynGen advances regenerative medicine and other emerging applications for high-value cells by providing researchers, clinicians and manufacturers with innovative, robust systems that improve the recovery, purity and viability of stem and other clinically important cells from umbilical cord blood, peripheral blood, bone marrow, and cell culture.